Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
A total of 1,197 patients were randomized in a 2:1 ratio to receive semaglutide 2.4 mg subcutaneously once weekly or placebo for 240 weeks
You should not take Mounjaro if you: Have a personal or family history of medullary thyroid carcinoma (MTC) Have multiple endocrine neoplasia syndrome type 2 (MEN 2) Have a known allergy to tirzepatide or any of the other ingredients in Mounjaro Are pregnant, breastfeeding, or planning to become pregnant in the near future Have a history of pancreatitis Have severe gastrointestinal disease (such as gastroparesis) Patients with type 1 diabetes, a history of eating disorders, or those taking certain medications (particularly insulin or sulphonylureas) require careful assessment before starting treatment
Low fluid intake further reduces saliva production and may even cause the saliva to become thick and frothy and the tongue to become sticky
Precautions for Sensitive Groups: Patients with a history of mental health conditions, diabetic retinopathy, or cardiovascular conditions should discuss these with their provider before starting
What animal models and community sources describe: Anti-catabolic signaling activates within hours
US$ 29.34
US$ 25.76
US$ 22.97
US$ 27.55
